Inspire Medical Systems, Inc. to Report Fourth Quarter and Fiscal 2024 Financial Results on February 10, 2025

Rhea-AI Summary

Inspire Medical Systems (NYSE: INSP) has announced it will release its fourth quarter and fiscal 2024 financial results after market close on Monday, February 10, 2025. The company's management will host a conference call at 5:00 p.m. Eastern Time to discuss financial results and recent business developments.

The earnings call will be accessible through two options: a webcast via the company's Investor Relations page for those planning to listen only, and a separate registration link for participants who wish to ask questions. Participants planning to ask questions are advised to register at least 10 minutes before the call. A replay will be available on the Investor Relations website approximately two hours after the event and will remain archived for two weeks.

MINNEAPOLIS, Jan. 07, 2025 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire) will release financial results for the fourth quarter and fiscal 2024 after the close of trading on Monday, February 10. Inspire’s management team will host a corresponding conference call beginning at 5:00 p.m. Eastern Time to discuss the financial results and recent business developments.

A webcast of the call will be accessible via the Investor Relations page of the Inspire website or through this link: Inspire's Q4 2024 earnings call webcast. For those not planning to ask a question of management, the Company recommends listening via the webcast.

If you plan to ask a question, please use the following link: Inspire's Q4 2024 earnings call. After registering, an email will be sent, including dial-in details and a unique conference call access code required to join the live call. To ensure you are connected prior to the beginning of the call, the Company suggests registering a minimum of 10 minutes before the start of the call. 

Following the call, a replay will be available on the Company's Investor Relations website approximately two hours after the event and archived on the site for two weeks.

About Inspire Medical Systems
Inspire is a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea. Inspire’s proprietary Inspire therapy is the first and only FDA, EU MDR, and PDMA-approved neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea.

For additional information about Inspire, please visit www.inspiresleep.com.

Investor and Media Contact
Ezgi Yagci
Vice President, Investor Relations
ezgiyagci@inspiresleep.com
617-549-2443

FAQ

When will Inspire Medical Systems (INSP) report Q4 2024 earnings?

Inspire Medical Systems will report its Q4 and fiscal 2024 earnings after market close on Monday, February 10, 2025.

What time is Inspire Medical Systems' (INSP) Q4 2024 earnings call?

The earnings conference call will begin at 5:00 p.m. Eastern Time on February 10, 2025.

How can investors access Inspire Medical Systems' (INSP) Q4 2024 earnings call?

Investors can access the call either through the webcast on Inspire's Investor Relations page or by registering for the conference call if they plan to ask questions.

How long will Inspire Medical Systems' (INSP) Q4 2024 earnings call replay be available?

The earnings call replay will be available on the company's Investor Relations website for two weeks following the call.